Full Alliance Group Inc FAGI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FAGI is a good fit for your portfolio.
News
-
Full Alliance Group, Inc. (OTC: FAGI) and DynaMAXX Health, Inc. Announce its Grand Opening of the First Ever Cash Pay Anti-Aging and Rejuvenation Direct Sales MAXX Health Clinic, in The Villages, Florida
-
Full Alliance Group, Inc. Congratulates Corinne Sanzone and Leslie DuRant of Our Clean Paws, Inc. on Their Feature on Fox & Friends
-
Full Alliance Group, Inc.’s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $1.16 Mil
- Volume/Avg
- 34,335 / 74,183
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Full Alliance Group Inc provides nutraceutical and supplement products; extracorporeal blood oxygenation and ozonation treatments for patients. The company derives revenues from merchandise sales from physical locations and online channels.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
|
Metric
|
FAGI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FAGI
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
FAGI
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Vrjrfcsl | Djhqb | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Gxnxprqcpy | Hrytjf | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Dnsmqhw | Sjhn | $41.4 Bil | |||
| Viatris Inc
VTRS
| Txrmrqzzx | Ywnw | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fgjxqyhb | Xgrjn | $13.7 Bil | |||
| Catalent Inc
CTLT
| Vsnndhtds | Nqfhsf | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Tcvkhftt | Nhlyc | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Xhbtzcpg | Qkzhnb | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Yldyyslt | Wxsq | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Wqyttmxsk | Mjm | $2.7 Bil |